SCHEMBL19258547

SCHEMBL19258547

NC(=O)Nc1cc(C(F)(F)F)nn1-c1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNJ6 P48051 1/20 0.63
KCNJ5 P48544 1/20 0.63
KCNJ3 P48549 1/20 0.63
NR3C2 P08235 1/20 0.61
CDK8 P49336 1/20 0.60
MAPK13 O15264 9/20 0.54
MAPK12 P53778 9/20 0.54
MAPK11 Q15759 9/20 0.54
MAPK14 Q16539 9/20 0.54
JAK2 O60674 1/20 0.53
GAA P10253 1/20 0.52
PTGS1 P23219 1/20 0.51
PDPK1 O15530 1/20 0.50
GRM5 P41594 1/20 0.50
ALDH1A1 P00352 1/20 0.50
HTT P42858 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1780615 0.90 KCNJ6 (0.67) KCNJ6KCNJ5KCNJ3MAPK13MAPK12
SCHEMBL5164195 0.86 CDK8 (0.80) CDK8MAPK13MAPK12MAPK11MAPK14
Hydrochloric Acid SCHEMBL29397175 0.85 CDK8 (0.78) CDK8MAPK13MAPK12MAPK11MAPK14
SCHEMBL1013684 0.82 KCNJ6 (0.58) KCNJ6KCNJ5KCNJ3MAPK13MAPK12
SCHEMBL27584609 0.78 KLKB1 (0.61) KCNJ6KCNJ5KCNJ3NR3C2PTGS1
SCHEMBL13975495 0.78 NTRK1 (0.78) KCNJ6KCNJ5KCNJ3GAAALDH1A1
SCHEMBL29397706 0.77 KCNJ6 (0.70) KCNJ6KCNJ5KCNJ3CDK8MAPK13
SCHEMBL8638165 0.77 PTGS2 (0.60) GAAPTGS1PDPK1GRM5
SCHEMBL6127413 0.76 NR3C2 (1.00) NR3C2PTGS1PDPK1
SCHEMBL1010908 0.76 KCNJ6 (0.84) KCNJ6KCNJ5KCNJ3MAPK13MAPK12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9730937-B2 RAF kinase modulator compounds and methods of use thereof AMBIT BIOSCIENCES CORPORATION (US) 2017-08-15 US disclosed
CN-102026985-A Quinazoline derivatives as RAF kinase modulators and methods and uses thereof AMBIT BIOSCIENCES CORPORATON 2011-04-20 CN disclosed
CN-101553232-A Kinase inhibitors useful for the treatment of proliferative diseases DECIPHERA PHARMACEUTICALS LLC (US) 2009-10-07 CN disclosed